ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 141,46
-0,67%
Dow Jones
39 859,14
0,13%
DAX
18 726,76
-0,21%
Brent Oil
82,70
-0,99%
Bitcoin
69 727,35
-2,41%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Pieris Pharmaceuticals Inc (PIRS)

  7. Pieris Pharmaceuticals Inc (PIRS) Actualités

PIRS

Pieris Pharmaceuticals (PIRS)

Pieris Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PIRS
DateHeureSourceTitreSymboleSociété
15/05/202422h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PIRSPieris Pharmaceuticals Inc
09/05/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PIRSPieris Pharmaceuticals Inc
14/02/202422h37Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PIRSPieris Pharmaceuticals Inc
31/08/202322h15Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:PIRSPieris Pharmaceuticals Inc
10/08/202323h04Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PIRSPieris Pharmaceuticals Inc
26/06/202323h26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PIRSPieris Pharmaceuticals Inc
23/06/202322h47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PIRSPieris Pharmaceuticals Inc
12/06/202312h43Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PIRSPieris Pharmaceuticals Inc
22/05/202323h01Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PIRSPieris Pharmaceuticals Inc
11/05/202312h02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PIRSPieris Pharmaceuticals Inc
28/04/202322h22Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:PIRSPieris Pharmaceuticals Inc
28/04/202322h20Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PIRSPieris Pharmaceuticals Inc
31/03/202322h05Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PIRSPieris Pharmaceuticals Inc
14/02/202322h19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PIRSPieris Pharmaceuticals Inc
03/01/202322h56Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:PIRSPieris Pharmaceuticals Inc
04/11/202222h11Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PIRSPieris Pharmaceuticals Inc
04/08/202223h06Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PIRSPieris Pharmaceuticals Inc
12/05/202212h02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:PIRSPieris Pharmaceuticals Inc
29/04/202222h12Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PIRSPieris Pharmaceuticals Inc
08/01/202215h15TipRanksAnalysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Pieris Pharmaceuticals (PIRS) and Biohaven Pharmaceutical Holding Co (BHVN)NASDAQ:PIRSPieris Pharmaceuticals Inc
16/08/202112h36Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PIRSPieris Pharmaceuticals Inc
05/08/202122h49Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PIRSPieris Pharmaceuticals Inc
25/06/202112h18TipRanksWhat Makes Penny Stock Pieris Pharma A “Strong Buy”?NASDAQ:PIRSPieris Pharmaceuticals Inc
01/06/202122h02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:PIRSPieris Pharmaceuticals Inc
27/05/202100h37TipRanksPieris: Shares Can Still Soar Much Higher, Says AnalystNASDAQ:PIRSPieris Pharmaceuticals Inc
25/06/202023h00Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:PIRSPieris Pharmaceuticals Inc
20/11/201914h10Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:PIRSPieris Pharmaceuticals Inc
08/11/201814h00GlobeNewswire Inc.Pieris Pharmaceuticals to Present at Investor Conferences in NovemberNASDAQ:PIRSPieris Pharmaceuticals Inc
07/11/201813h00GlobeNewswire Inc.Pieris Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate UpdateNASDAQ:PIRSPieris Pharmaceuticals Inc
31/10/201813h00GlobeNewswire Inc.Pieris Pharmaceuticals to Host Third Quarter 2018 Investor Call and Corporate Update on November 7, 2018NASDAQ:PIRSPieris Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PIRS

Dernières Valeurs Consultées

EU
MC
Lvmh Moet Hennessy Louis...
NASDAQ
MSFT
Microsoft
EU
VK
Vallourec
EU
ACA
Credit Agricole
EU
VIV
Vivendi
NASDAQ
GOOGL
Alphabet
NASDAQ
AAPL
Apple
EU
LR
Legrand
NYSE
JPM
JP Morgan Chase
EU
BN
Danone
EU
BNP
BNP Paribas
NYSE
MCD
McDonalds
EU
SGO
Cie de SaintGobain
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés